Guardion Health Sciences, Inc. (GHSI)

Guardion Health Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-5.12	0.16	-14.92	-24.75	-8.57	-10.88
Depreciation & Amortization	0.02	0.02	1.25	0.78	0.22	0.63
Other Amortization	-	-	-	-	-	0.25
Loss (Gain) From Sale of Assets	-0.13	-0.13	0.01	0.16	0.02	-
Asset Writedown & Restructuring Costs	-	-	10.07	11.89	0.03	1.56
Stock-Based Compensation	-0	0.01	0.31	1.27	-0.4	2.72
Provision & Write-off of Bad Debts	0	0	0	0.02	-	-
Other Operating Activities	1.31	-3.86	-2.27	0.41	0.98	0.12
Change in Accounts Receivable	-0.16	-0.35	-0.09	0.38	0.07	-0.05
Change in Inventory	0.8	0.32	-2.81	0.45	-0.73	0.05
Change in Accounts Payable	-0.48	-0.9	1.28	-0.68	0.48	-0.01
Change in Other Net Operating Assets	0.51	0.37	-0.27	-0.59	-0.12	-0.42
Operating Cash Flow	-3.25	-4.37	-7.45	-10.64	-8.01	-6.03
Capital Expenditures	-0	-0	-0.01	-0.07	-0.04	-0.17
Cash Acquisitions	-	-	-	-25.94	0.01	-
Divestitures	0.02	0.02	-	-	-	-
Investment in Securities	-	-	5	-5	-	-
Investing Cash Flow	0.02	0.02	4.99	-31.01	-0.03	-0.17
Short-Term Debt Issued	-	-	-	-	-	0.35
Total Debt Issued	-	-	-	-	-	0.35
Short-Term Debt Repaid	-	-	-	-	-	-0.1
Total Debt Repaid	-	-	-	-	-	-0.1
Net Debt Issued (Repaid)	-	-	-	-	-	0.25
Issuance of Common Stock	0.06	0.06	9.97	37.23	5.45	16.4
Repurchase of Common Stock	-	-	-0.01	-	-	-
Financing Cash Flow	0.06	-5.19	14.27	37.23	5.45	16.65
Net Cash Flow	-3.17	-9.55	11.81	-4.42	-2.6	10.44
Free Cash Flow	-3.25	-4.37	-7.45	-10.72	-8.05	-6.2
Free Cash Flow Margin	-26.92%	-35.71%	-67.44%	-148.19%	-426.21%	-686.77%
Free Cash Flow Per Share	-2.55	-3.44	-6.65	-22.62	-28.25	-51.01
Cash Interest Paid	-	-	-	-	0.01	-
Levered Free Cash Flow	-2.31	0.33	-8.16	-6.75	-5.09	-2.88
Unlevered Free Cash Flow	-2.31	0.33	-8.16	-6.75	-5.09	-2.97
Change in Net Working Capital	0.09	-2.77	5.13	2.18	-0.83	0.55

Source: S&P Capital IQ. Standard template.